SAFETY AND EFFICACY OF RUXOLITINIB IN PATIENTS WITH DIPSS INTERMEDIATE-1-RISK MYELOFIBROSIS (MF) FROM JUMP: AN OPEN LABEL, MULTICENTER, SINGLE-ARM, EXPANDED-ACCESS STUDYF. Passamonti,A. Zaritskey,P. Giraldo,A. M. Liberati,D. Niederwieser,F. Palandri,P. Raanani,M. Griesshammer,A. M. Vannucchi,H. K. Al-Ali,V. Gupta,B. Martino, L. Foltz, J. Perez Ronco, J. Ghosh, C. Bouard,R. TavaresHAEMATOLOGICA（2016）引用 22|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
